Amani Therapeutics

New York, United States · Founded 2025 · $25.0M raised

Headquarters
New York
Employees
11–50
Founded
2025
Business Model
B2B2C
Total Funding
$25.0M
Last Round
$25.0M Series AMar 2026
Rounds
1

About

Amani Therapeutics is a New York-based biopharmaceutical company developing safer, more effective treatments for serious psychiatric illness. Its lead program, AM-01, is a fixed-dose combination of clozapine and a Phase 3-ready novel chemical entity in-licensed from AstraZeneca, designed to deliver clozapine's unmatched efficacy for treatment-resistant schizophrenia while addressing its most significant safety liability, severe neutropenia, and reducing the burdensome blood-monitoring requirements that limit its use today.

Summary

Amani Therapeutics is a Biotech company based in New York, United States, founded in 2025. It has raised $25.0M in total across 1 round, most recently a $25.0M Series A round in Mar 2026. Investors include RTW Investments.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries AMar 2026
$25.0M

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Amani Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/amani-therapeutics"><img src="https://indexed.vc/api/badge/company/amani-therapeutics" alt="Amani Therapeutics on Indexed.vc" width="260" height="76" /></a>